Gene A. Lang, Ph.D.
Dr. Gene A. Lang is focuses his practice on patent preparation and prosecution. Gene brings over 10 years of experience and works primarily on life science technologies for universities and multinational pharmaceutical companies. His practice involves the preparation, prosecution and management of global patent portfolios in a variety of technologies.
Gene has experience preparing and prosecuting life science, pharmaceutical, medical device, material sciences and clean technology patent applications. Additionally, his practice includes conducting and performing due diligence investigations and preparing opinions of counsel, including patentablity, infringement and invalidity opinions.
Gene also has experience representing pharmaceutical companies in Hatch Waxman/Abbreviated New Drug Application (ANDA) litigation. His experience includes all aspects of fact and expert discovery and pre-trial preparations.
Prior to his legal career, Gene was a pre-doctoral research fellow at the University of Texas-Houston MD Anderson Cancer Center, where he developed mouse models of human cancers and researched mechanisms of cancer metastasis. His research experience includes cellular and molecular biology, embryonic stem cell manipulation, recombinant DNA techniques, embryology and genomics. His research is published in several scientific journals, including Cell, Nature Genetics, and Genes & Development.
- Not yet licensed in Massachusetts - pending admission by motion
- New Jersey
- District of Columbia Bar
- U.S. Patent and Trademark Office
- U.S. District Court, Southern District of Florida
- U.S. District Court, District of New Jersey
- Selected for Florida Super Lawyers "Rising Stars," 2017-2018
- The Florida Bar - Board Certified Specialist in Intellectual Property Law
- Boston Patent Law Association, Member, 2019-present
- Intellectual Property Law Association of Florida, President, 2017; Vice-president, 2016; Secretary, 2015
- Miami-Dade Beacon Council Life Sciences and Healthcare Committee, Member, 2016-2018
- BioFlorida, member, Leadership committee – Southeast Chapter, 2015-2018
- Dade County Bar Association, Member, 2015-2018
- Gainesville Area Innovation Network – Stakeholder, 2014-2015
- Author, Race to Patent, FORWARD Florida Magazine, Issue 2, 2013
- Author, The Patentability of DNA, Dade County Bar Association Bulletin, 2011
- Co-Author, The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss, Genes & Development, v. 22, p. 1337-1344, 2008
- Co-Author, An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations, Journal of Clinical Investigation, v. 117, p. 1893-1901, 2007
- Co-Author, Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome, Cell, v. 119, p. 861-872, 2004
- Co-Author, Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice, Nature Genetics, v. 36, p. 63-68, 2004
- Co-Author, Extragenic suppressors of the nimX2 (cdc2) mutation of Aspergillus nidulans affect nuclear division, septation and conidiation, Genetics, v. 156, p. 1573-1584, 2000
- Moderator, “Patent Management from the Inside: A Dialogue between Internal and External Professionals,”Association of University Technology Managers Annual Meeting, March 2017
- Speaker, “Introduction to Intellectual Property,” Cambridge Innovation Center, Miami, FL, August 2017
- Speaker, “Patents in the Life Sciences,” Life Sciences South Florida, January 2014
- Guest Lecturer, “Patents and Technology Transfer”, Florida International University, 2014
28 State StreetSuite 700Boston, MA 02109
University of New Hampshire Franklin Pierce School of Law, J.D., 2007
University of Texas-Houston, M.D. Anderson Cancer Center, Ph.D., Genes & Development/Cancer Biology, 2004
Millsaps College, B.S., Biology, cum laude, 1997